Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - AMERICAN GENE ENGINEER CORP | ex32_1.htm |
EX-31.2 - EXHIBIT 31.2 - AMERICAN GENE ENGINEER CORP | ex31_2.htm |
EX-31.1 - EXHIBIT 31.1 - AMERICAN GENE ENGINEER CORP | ex31_1.htm |
10-Q - FOR THE QUARTERLY PERIOD ENDED JULY 31, 2016 - AMERICAN GENE ENGINEER CORP | g91516010q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Gene Engineer Corp. (the "Company") on Form 10-Q for the quarter ended July 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Han-Chen Lin, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: September 20, 2016
/s/ Han-Chen Lin
|
|
Han-Chen Lin
Principal Financial Officer and Principal
Accounting Officer
|